Geopolitics
The Illusion of Mercy: US Tariff Waivers and the Upstream Trap in India-China Pharma Dependency
The United States has exempted India's generic drug manufacturers from new tariffs, yet a critical vulnerability persists within India's pharmaceutical supply chain due to its reliance on upstream inputs from China. This move, while offering temporary relief, exposes the profound and dangerous interdependencies in a global supply chain rigged by Western policies, highlighting a crisis that the West itself helped create and now must confront.
